Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bax'

Search results for: 'research area apoptosis bax'

Items 61-70 of 420

Page
per page
  1. TLQP 21
    A4475 TLQP 21
    Summary: VGF-derived peptide
      Soluble to 1 mg/mL
  2. Mdivi 1
    A4472 Mdivi 1
     1 Citation
    Summary: Selective DRP1/Dnm1 inhibitor, cell-permeable
      insoluble in H2O; insoluble in EtOH; ≥17.65 mg/mL
  3. C 75
    A4449 C 75
    Summary: Fatty acid synthase (FAS) inhibitor
      ≥22.5 mg/mL
  4. CHM 1
    A4450 CHM 1
    Summary: Tubulin polymerization inhibitor
      <7.08 mg/mL
  5. Cytochrome c fragment (93-108)
    A1062 Cytochrome c fragment (93-108)
    Summary: Initiates apoptosis
      ≥180.5 mg/mL
  6. GRI 977143
    A4471 GRI 977143
    Summary: LPA2 receptor non-lipid agonist
      Soluble in DMSO
  7. Pifithrin-μ
    A4482 Pifithrin-μ
     1 Citation
    Target: Autophagy|p53|HSP70
    Summary: Inhibitor of p53 binding and anti-apoptotic
      insoluble in H2O; ≥18.1 mg/mL
  8. LCL161
    A3541 LCL161
     1 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: Antagonist of IAPs inhibitor
      ≥25.05 mg/mL
  9. 3,3'-Diindolylmethane
    A3118 3,3'-Diindolylmethane
    Summary: Anticancer and antineoplastic agent
      insoluble in H2O; ≥11.15 mg/mL
  10. JNJ-26854165 (Serdemetan)
    A4204 JNJ-26854165 (Serdemetan)
     1 Citation
    Target: p53|HDM2 ubiquitin ligase
    Summary: P53 activator, blocking Mdm2-p53 interaction
      insoluble in EtOH; insoluble in H2O; ≥14.8 mg/mL

Items 61-70 of 420

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 217item
  2. Natural Products 14item
  3. Protein 12item
  4. Kits 83item
  5. Screening Library 31item
  6. Peptides 1 item
  7. Probes & Dyes 2item
  8. Cell Biology 30item
  9. Peptides & Proteins 51item
  10. Protein & Immunology 1 item
  11. Lab Reagents 1 item
Specificity
  1. Selective 56item
Reversibility
  1. Reversible 1 item
  2. Irreversible 6item
Target
  1. Caspases 12item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 2item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 4item
  6. Inhibitor of apoptosis proteins (IAP) 2item
  7. Bcl-2 5item
  8. Raf 2item
  9. Aurora Kinases 1 item
  10. Bcl-xl 2item
  11. MDM2 2item
  12. AP-1 1 item
  13. DT-diaphorases 1 item
  14. GSK-3 1 item
  15. VEGFR 3item
  16. PDGFR 2item
  17. c-Kit 2item
  18. RET 1 item
  19. Mcl-1 2item
  20. Thymidylate Synthase 1 item
  21. JNK 1 item
  22. Nrf2 1 item
  23. Sir2-like Family Deacetylases (Sirtuins) 1 item
  24. Deubiquitinating enzymes (DUBs) 1 item
  25. Trk Receptors 1 item
  26. Aminopeptidases 1 item
  27. STAT 1 item
  28. Estrogen and Related Receptors 1 item
  29. EGFR 1 item
  30. RIP kinases 1 item
  31. Hypoxia Inducible Factors (HIFs) 1 item
  32. JAK 3item
  33. HSP90 1 item
  34. Topoisomerases 1 item
  35. Cytochrome P450 (CYP450) 1 item
  36. Survivin 1 item
  37. Ubiquitin-specific proteases 1 item
  38. Melanocortin (MC) Receptors 1 item
  39. MK2 1 item
  40. Fatty-acid-binding proteins (FABPs) 1 item
  41. Autophagy 1 item
  42. COX 1 item
  43. NADPH Oxidases 1 item
  44. MAGL 1 item
  45. Histamine H1 Receptors 1 item
  46. iNOS 1 item
  47. TRP Channel 1 item
  48. Apoptosis Inducers 1 item
  49. Glucocorticoid Receptors 1 item
  50. Cdc7 1 item
  51. angiogenesis 1 item
  52. c-RET 1 item
  53. FPTase 1 item
  54. sodium channels 1 item
  55. p53 4item
  56. cysteine protease 1 item
  57. HDM2 ubiquitin ligase 1 item
  58. PC-PLC 1 item
  59. Glucosidases 1 item
  60. HIV 1 item
  61. Histone Acetyltransferases (HATs) 1 item
  62. Telomerases 1 item
  63. Tyrosinases 1 item
  64. HSP70 1 item
  65. phosphatidylinositol kinase 1 item
  66. Adenosine Deaminases 1 item
  67. p21 1 item
  68. DHFR 1 item
  69. GARFT 1 item
  70. RHA 1 item
  71. TRPC channel 1 item
  72. PKD 1 item
  73. Bcl-w 1 item
  74. Bax 1 item
  75. NS3/4a Proteases 1 item
Reported Experiments
  1. Animal Experiments 72item
  2. Cell Experiments 64item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 44item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 5item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. HCV 1 item
  11. Hepatocellular Carcinoma 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 1 item
  14. Lung Cancer 2item
  15. Lymphoma 4item
  16. Melanoma 4item
  17. Multiple Myeloma 1 item
  18. Myelofibrosis 1 item
  19. Myeloma 1 item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 2item
  22. Ovarian Cancer 1 item
  23. Pain Relief 1 item
  24. Pancreatic Cancer 3item
  25. Pentacyclic Triterpenoid 1 item
  26. Prostate Cancer 7item
  27. Pulmonary Fibrosis 1 item
  28. Rheumatoid Arthritis 2item
  29. Soft Tissue Sarcoma 1 item
  30. Testicular Cancer 1 item
  31. Type 2 Diabetes 2item